Case Report
A Case of New-Onset Dermatomyositis in the Second Trimester of Pregnancy: A Case Report and Review of the Literature
Table 1
Dermatomyositis complicating pregnancy. Review of the cases.
| Author [ref.] | Patient | Age at diagnosis (years) | DM onset | Disease activity (during pregnancy) | Treatment | Fetal outcome |
| Glickman [7] | 1 | 27 | BP | Improved | Prednisone | Healthy |
| Masse [8] | 1 | 26 | BP | Improved | ACTH | Healthy | | | | Inactive | ACTH | Abortion |
| Tsai et al. [9] | 1 | 33 | DP | Active | No treatment | Neonatal death |
| Gutierrez et al. [6] | 1 | NI | DP | Active | Prednisone | Abortion | 2 | NI | DP | Active | Prednisone | Stillbirth | 3 | JDM | BP | Inactive | No treatment | Abortion | | | | Exacerbation | Prednisone | Premature | 4 | NI | PP | Inactive | No treatment | Abortion | | | | Inactive | No treatment | Caesarean at term | 5 | NI | BP | Inactive | No treatment | Healthy | 6 | NI | BP | Exacerbation | Prednisone | Premature | | | | Inactive | No treatment | Twins Premature/neonatal death |
| King and Chow [10] | 1 | 12 | BP | Inactive | No treatment | IUGR | | | | Inactive | No treatment | Healthy | 2 | 20 | BP | Inactive | No treatment | Healthy | | | | Inactive | No treatment | Healthy | 3 | 25 | BP | Exacerbation | Prednisone | Healthy |
| England et al. [11] | 1 | 35 | DP | Active | Steroid | IUGR |
| Ishii et al. [12] | 1 | 31 | DP | Active | Steroid | Healthy | | | | Inactive | Steroid | Healthy |
| Pinheiro Gda et al. [2] | 1 | 14 | DP | Active | Steroid | Healthy |
| Suwa et al. [13] | 1 | 29 | PP | — | Spontaneous remission | — |
| Harris et al. [14] | 1 | 29 | DP | Active | Induced labor, pulse steroid PP | Healthy |
| Solomon and D’Alton [15] | 1 | 28 | DP | Active | Steroid | Healthy |
| Kofteridis et al. [16] | 1 | 25 | DP | Active | Pulse steroid | Abortion |
| Kanoh et al. [17] | 1 | 33 | PP | — | Prednisolone PP | — |
| Lee and Yoo [18] | 1 | 33 | PP | — | Methylprednisolone PP | — |
| Silva et al. [4] | 1 | 22 | BP | Active, no change | Steroid, MTX | Abortion | 2 | 28 | BP | Inactive | Prednisolone | Healthy |
| Park et al. [19] | 1 | 22 | DP | Active | Therapeutic abortion, IVIG PP | Abortion |
| Mosca et al. [20] | 1 | 32 | DP | Active | Methylprednisolone, IVIG | Healthy |
| Pasrija et al. [21] | 1 | 27 | DP | Active | Dexamethasone, HCQ | Healthy |
| Váncsa et al. [22] | 1 | 22 | BP | Inactive | Methylprednisolone | Healthy | | | | Inactive | Methylprednisolone | Abortion | 2 | 28 | BP | Inactive | Methylprednisolone | Healthy | 3 | 33 | BP | Inactive | No treatment | Healthy | 4 | 37 | DP | Active | Methylprednisolone | Premature | 5 | 30 | BP | Inactive | No treatment | Healthy |
| Chopra et al. [23] | 1 | 28 | BP | Inactive | No treatment | Healthy | | | | Inactive | No treatment | IUGR |
| Nozaki et al. [24] | 1 | 31 | DP | Active | Prednisolone, IVIG PP | Premature |
| Linardaki et al. [25] | 1 | 42 | DP | Active | Methylprednisolone, IVIG | Healthy |
| Madu et al. [26] | 1 | JDM | BP | Exacerbation | Prednisolone | Healthy |
| Pinal-Fernandez et al. [3] | 1 | 35 | BP | Improvement | Prednisone, MTX | Induced abortion | | | | Improvement | Prednisone | Healthy | | | | Improvement | Prednisone | Healthy | 2 | 35 | BP | Improvement | Prednisone | Healthy | | | | Improvement | Prednisone | Healthy | 3 | 38 | BP | Improvement | Prednisone | Induced abortion (anencephaly) | | | | Improvement | Prednisone | Healthy | | | | Improvement | Prednisone | Healthy | 4 | 32 | PP | — | Prednisone PP | — | 5 | 31 | BP | Asymptomatic | No treatment | Healthy | | | | Asymptomatic | No treatment | Abortion | 6 | 36 | BP | No change | Prednisone | Healthy |
| Present case | 1 | 40 | DP | Active | Methylprednisolone | Premature |
|
|
BP, before pregnancy; DP, during pregnancy; PP, puerperal period; NI, not indicated; JDM, juvenile dermatomyositis; ACTH, adrenocorticotrophic hormone; IVIG, intravenous immunoglobulin; MTX, methotrexate; HCQ, hydroxychloroquine; IUGR, intrauterine growth restriction.
|